Table 1 Table of patient clinical characteristics
ID | Sex | Age | Neoadjuvant therapy | RCPath | Resection tissue | Staging | ||
|---|---|---|---|---|---|---|---|---|
T | N | M | ||||||
1 | M | 73 | 50.4/28 + 5fu | A | x | 3 | 2 | 0 |
2 | F | 42 | 54/30 + 5fu | A | x | 2,3 | 1,2 | 0 |
3 | F | 38 | 50.4/28 + 5fu | A | x | 3 | 1 | x |
4 | M | 75 | 54/31 + 5fu | A | x | 3 | 2 | x |
5 | M | 51 | 50.4/28 + 5fu | A | x | 3 | 2 | 0 |
6 | M | 66 | 50.4/28 + 5fu | B | √ | 3 | 0,1 | 0 |
7 | M | 57 | 50.4/28 + 5fu | B | √ | 3 | 1,2 | 0 |
8 | F | 72 | 50.4/28 + 5fu | B | x | 3 | 2 | 0 |
9 | M | 65 | 50.4/28 + 5fu | B | x | 3 | x | x |
10 | M | 65 | 50.4/28 + 5fu | B | x | 3 | 2 | x |
11 | F | 64 | 42.2/20 + 5fu | B | x | 2 | 0 | 0 |
12 | F | 60 | 50.4/28 + 5fu | B | x | 2 | 0 | x |
13 | M | 66 | 50.4/28 + 5fu | B | x | 3 | 2 | 0 |
14 | M | 67 | 50.4/28 + 5fu | B | x | 3 | 1 | 0 |
15 | M | 67 | 54/30 + 5fu | B | x | 3 | 1 | x |
16 | F | 55 | 55.4/30 + 5fu | C | √ | 3 | 2 | 0 |
17 | F | 75 | 45/25 + 5fu/RP | C | x | 3 | 0 | 0 |
18 | M | 70 | 50.4/28 + 5fu | C | √ | 3 | 2 | 0 |
19 | M | 79 | 50.4/28 + 5fu | C | x | 3 | 2 | 0 |
20 | M | 76 | 43.2/25 + 5fu | C | √ | 3 | 2 | 0 |
21 | M | 48 | 50.4/28 + 5fu | C | x | 3 | 0 | 0 |
22 | M | 44 | 50.4/30 + 5fu | C | √ | 3 | 2 | 0 |
23 | M | 47 | 50.4/28 + 5fu | C | √ | 3 | 2 | x |
24 | M | 74 | 50.4/28 + 5fu | C | √ | 3 | 2 | x |
25 | M | 45 | 50.4/28 + 5fu | C | x | 3 | 2 | x |
26 | M | 62 | 50.4/30 + 5fu | C | x | 3 | 1 | x |
27 | M | 64 | 50.4/28 + 5fu | C | x | 3 | 1 | x |
28 | F | 41 | 50.4/28 + 5fu | C | x | 3 | 1 | x |
29 | M | 71 | 50.4/28 + 5fu | C | x | 3 | 2 | x |